A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)

NCT00246337 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Comparator: Placebo
DRUG: MK0974
DRUG: MK0974
DRUG: MK0974
DRUG: MK0974
DRUG: MK0974
DRUG: MK0974
DRUG: MK0974
DRUG: Rizatriptan

Sponsor

Merck Sharp & Dohme LLC